PROSPECTS AND OPPORTUNITIES
Growth is set to be driven by steady demand and the growing presence of affordable generics
Value sales of analgesics are expected to rise in Belgium over the forecast period overall. As a core category within the OTC healthcare market, demand for pain relief remains resilient, driven by recurring needs such as headaches, muscular pain, fever, and minor injuries.
Innovation is set to focus on combination analgesic and natural alternatives to topical analgesics
Combination products, such as those containing both paracetamol and ibuprofen, are gaining momentum as consumers seek multi-action pain relief. This trend is expected to continue over the forecast period, driving further product development within oral analgesics.
Regulatory changes are expected to shape analgesics across the forecast period
Recent regulatory changes are set to impact analgesics over the forecast period. In September 2024, a new Royal Decree was introduced to regulate the import of unlicensed medicines, including analgesics.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Belgium with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Belgium, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Belgium report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Belgium?
- Which are the leading brands in Analgesics in Belgium?
- How are products distributed in Analgesics in Belgium?
- How has the regulatory and operating environment for Analgesics changed in Belgium?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Belgium - Category analysis
KEY DATA FINDINGS
Value growth is driven by consumer trust, format innovation, and demand for fast-acting relief
UPSA Médica NV SA retains its lead while branded players are increasingly challenged by generics
Pharmacies remain the main distribution channel while retail e-commerce gains ground
Growth is set to be driven by steady demand and the growing presence of affordable generics
Innovation is set to focus on combination analgesic and natural alternatives to topical analgesics
Regulatory changes are expected to shape analgesics across the forecast period
Consumer Health in Belgium - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!